{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:16:10Z","timestamp":1786374970155,"version":"build-2736575974"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218373","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T17:29:08Z","timestamp":1561138148000},"page":"e0218373","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Using Directly Observed Therapy (DOT) for latent tuberculosis treatment \u2013 A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GA"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8223-5716","authenticated-orcid":true,"given":"Udodirim","family":"Onwubiko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-2004","authenticated-orcid":true,"given":"Kristin","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Marie","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-1563","authenticated-orcid":true,"given":"David P.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"ref1","article-title":"The top 10 causes of death","year":"2017"},{"key":"ref2","unstructured":"Organization WH. Global tuberculosis report 2016. Geneva: World Health Organization, 2016. Available at: files\/14\/9789241565394-eng.pdf."},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6611a2","article-title":"Tuberculosis\u2014United States, 2016","volume":"66","author":"KM Schmit","year":"2017","journal-title":"MMWR. Morb. Mortal. Wkly. Rep"},{"key":"ref4","unstructured":"Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S095026881100286X","article-title":"Modelling tuberculosis trends in the USA","volume":"140","author":"AN Hill","year":"2012","journal-title":"Epidemiol. Infect"},{"key":"ref6","article-title":"Risk factors for tuberculosis","author":"P Narasimhan","year":"2013","journal-title":"Pulm Med"},{"key":"ref7","article-title":"Tuberculosis control in vulnerable groups","year":"2017"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup","volume":"179","author":"KM Shea","year":"2014","journal-title":"Am. J. Epidemiol"},{"key":"ref9","article-title":"CDC | TB | Treatment | Treatment Regimens for Latent TB Infection (LTBI)","year":"2017","journal-title":"CDC | TB | Treatment | Treatment Regimens for Latent TB Infection (LTBI)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"ofw082","DOI":"10.1093\/ofid\/ofw082","article-title":"Predictors of Latent Tuberculosis Infection Treatment After Introduction of a New Regimen: A Retrospective Cohort Study at an Inner City Clinic","volume":"3","author":"A Yamin","year":"2016","journal-title":"Open Forum Infect. Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12879-017-2245-8","article-title":"Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine","volume":"17","author":"AH McClintock","year":"2017","journal-title":"BMC Infect. Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3122\/jabfm.2017.04.170070","article-title":"Factors That Influence Treatment Completion for Latent Tuberculosis Infection","volume":"30","author":"MC Eastment","year":"2017","journal-title":"J. Am. Board Fam. Med"},{"key":"ref14","first-page":"1296","article-title":"Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons","volume":"127","author":"MN Lobato","year":"2005","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-016-1549-4","article-title":"Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review","volume":"16","author":"AL Stuurman","year":"2016","journal-title":"BMC Infect. Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12879-016-1550-y","article-title":"Initiation and completion rates for latent tuberculosis infection treatment: a systematic review","volume":"16","author":"A Sandgren","year":"2016","journal-title":"BMC Infect. Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: three decades of research. A comprehensive review","volume":"26","author":"E Vermeire","year":"2001","journal-title":"J. Clin. Pharm. Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.NNR.0000280660.26879.38","article-title":"Efficacy of Nurse Case-Managed Intervention for Latent Tuberculosis Among Homeless Subsamples","volume":"57","author":"A Nyamathi","year":"2008","journal-title":"Nurs. Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0749-3797(00)00283-X","article-title":"Incentives vs outreach workers for latent tuberculosis treatment in drug users","volume":"20","author":"CK Malotte","year":"2001","journal-title":"Am. J. Prev. Med"},{"key":"ref20","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Y Hirsch-Moverman","year":"2008","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0033354917694008","article-title":"Outbreak of Drug-Resistant Mycobacterium tuberculosis Among Homeless People in Atlanta, Georgia, 2008\u20132015","volume":"132","author":"KM Powell","year":"2017","journal-title":"Public Health Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3201\/eid2503.181678","article-title":"Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015\u20132017","volume":"25","author":"DP Holland","year":"2019","journal-title":"Emerg. Infect. Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.ASN.0000109668.05157.05","article-title":"Vascular Access and All-Cause Mortality: A Propensity Score Analysis","volume":"15","author":"KR Polkinghorne","year":"2004","journal-title":"J. Am. Soc. Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12874-015-0017-y","article-title":"An application of propensity score weighting to quantify the causal effect of rectal sexually transmitted infections on incident HIV among men who have sex with men","volume":"15","author":"AS Vaughan","year":"2015","journal-title":"BMC Med. Res. Methodol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies","volume":"46","author":"PC Austin","year":"2011","journal-title":"Multivariate Behav. Res"},{"key":"ref26","article-title":"Propensity score analysis and assessment of propensity score approaches using SAS procedures","author":"RE Lanehart","year":"2012","journal-title":"Propensity score analysis and assessment of propensity score approaches using SAS procedures"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The Central Role of the Propensity Score in Observational Studies for Causal Effects","volume":"70","author":"PR Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/1475-6773.12182","article-title":"Methods for Constructing and Assessing Propensity Scores","volume":"49","author":"MM Garrido","year":"2014","journal-title":"Health Serv. Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0272989X09341755","article-title":"The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies","volume":"29","author":"PC Austin","year":"2009","journal-title":"Med. Decis. Mak"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1037\/a0019623","article-title":"Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research","volume":"15","author":"VS Harder","year":"2010","journal-title":"Psychol. Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-7622-7-1","article-title":"Propensity scores in the presence of effect modification: A case study using the comparison of mortality on hemodialysis versus peritoneal dialysis","volume":"7","author":"YS Liem","year":"2010","journal-title":"Emerg. Themes Epidemiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies","volume":"69","author":"MC Elze","year":"2017","journal-title":"J. Am. Coll. Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1214\/07-STS227","article-title":"Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data","volume":"22","author":"JDY Kang","year":"2007","journal-title":"Stat. Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1037\/a0036515","article-title":"Examining moderation analyses in propensity score methods: application to depression and substance use","volume":"82","author":"KM Green","year":"2014","journal-title":"J. Consult. Clin. Psychol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study","volume":"12","author":"ND Goswami","year":"2012","journal-title":"BMC Public Health"},{"key":"ref36","article-title":"Can the poor adhere?","author":"JP Tulsky","journal-title":"Incentives for adherence to TB prevention in homeless adults"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1525-1446.2006.00605.x","article-title":"A Targeted Testing Program for Tuberculosis Control and Prevention Among Baltimore City\u2019s Homeless Population","volume":"24","author":"M Lashley","year":"2007","journal-title":"Public Health Nurs"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200209-998OC","article-title":"Safety of 2 Months of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis","volume":"167","author":"JE Stout","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"PC Austin","year":"2015","journal-title":"Stat. Med"},{"key":"ref40","article-title":"Cost-Effectiveness of Tuberculosis Screening and Observed Preventive Therapy for Active Drug Injectors at a Syringe-Exchange Program","author":"DC Perlman","year":"2001","journal-title":"Cost-Effectiveness of Tuberculosis Screening and Observed Preventive Therapy for Active Drug Injectors at a Syringe-Exchange Program"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pds.2256","article-title":"Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses","volume":"21","author":"JA Rassen","journal-title":"Pharmacoepidemiol. Drug Saf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:45:52Z","timestamp":1589039152000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218373"}},"subtitle":[],"editor":[{"given":"Amy","family":"Davidow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218373","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]}}}